Newborn Screening for Presymptomatic Diagnosis of Complement and Phagocyte Deficiencies

Mahya Dezfouli1,2, Sofia Bergström2, Lillemor Skattum3,4

  • 1Division of Clinical Immunology and Transfusion Medicine, Department of Laboratory Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden.

Insights

Early diagnosis of primary immunodeficiencies (PIDs) improves outcomes. A new multiplex protein profiling method for newborn screening can detect 22 PIDs from dried blood spots, enabling earlier intervention and better patient health.

Area of Science:

  • Immunology
  • Biochemistry
  • Genetics

Background:

  • Primary immunodeficiencies (PIDs) significantly impact patient health, with early diagnosis crucial for improved clinical outcomes.
  • Current diagnostic approaches often delay PID identification until severe symptoms manifest.
  • Integrating PID screening into existing newborn screening programs is essential for timely management and prevention.

Purpose of the Study:

  • To develop and validate a multiplex protein profiling method for the early diagnosis of primary immunodeficiencies (PIDs).
  • To enable parallel detection of 22 PIDs affecting complement and phagocytic functions using dried blood spot samples.
  • To establish a scalable diagnostic approach for population-wide newborn screening.

Main Methods:

  • Utilized multiplex protein profiling on small eluates from dried blood spots.
  • Developed a method for parallel diagnosis of 22 innate immunodeficiencies.
  • Validated the diagnostic approach through retrospective screening of patient samples.

Main Results:

  • Successfully developed a newborn screening method for 22 PIDs.
  • Demonstrated the applicability of the method for population-scale screening using dried blood spots.
  • Validated the diagnostic accuracy through retrospective analysis.

Conclusions:

  • The developed multiplex protein profiling method facilitates early and comprehensive diagnosis of PIDs.
  • This approach can be integrated into newborn screening programs for improved patient survival and quality of life.
  • Enables earlier detection of complement and phagocytic disorders, leading to better disease management.